These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1466343)

  • 1. Adult respiratory distress syndrome after streptokinase.
    Tio RA; Voorbij RH; Enthoven R
    Am J Cardiol; 1992 Dec; 70(20):1632-3. PubMed ID: 1466343
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypersensitivity reactions to streptokinase.
    Singh J; Hart G
    Eur Heart J; 1994 Aug; 15(8):1153-4. PubMed ID: 7988614
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypersensitivity vasculitis complicating intravenous streptokinase therapy in acute myocardial infarction.
    Ong AC; Handler CE; Walker JM
    Int J Cardiol; 1988 Oct; 21(1):71-3. PubMed ID: 3220603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult respiratory distress syndrome following thrombolytic therapy for pulmonary embolism.
    Martin TR; Sandblom RL; Johnson RJ
    Chest; 1983 Jan; 83(1):151-3. PubMed ID: 6848325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anaphylactic reaction in streptokinase therapy].
    Hohage H; Schulte B; Pfeiff B; Pullmann H
    Wien Klin Wochenschr; 1993; 105(6):176-8. PubMed ID: 8475630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous streptokinase therapy in acute myocardial infarct in a district hospital].
    Ziegler H
    Schweiz Med Wochenschr; 1988 Nov; 118(46):1698-701. PubMed ID: 3212422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and comparison of the adverse effects of streptokinase and alteplase.
    Tisdale JE; Colucci RD; Ujhelyi MR; Kluger J; Fieldman A; Chow MS
    Pharmacotherapy; 1992; 12(6):440-4. PubMed ID: 1492007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of intracoronary and intravenous streptokinase in an acute myocardial infarction. Experience from two community hospitals.
    Gann D; Wilcox J
    Ariz Med; 1984 Jun; 41(6):373-9. PubMed ID: 6466129
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction.
    Alexopoulos D; Raine AE; Cobbe SM
    Eur Heart J; 1984 Dec; 5(12):1010-2. PubMed ID: 6534748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic therapy for myocardial infarction: the problem, the promise and the price.
    Waters DD; Wiseman A
    CMAJ; 1988 Apr; 138(7):598-601. PubMed ID: 3128395
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitive reactions on readministration of streptokinase following acute myocardial infarction.
    Sahay RN; Kalantri SP; Gupta OP
    J Assoc Physicians India; 1994 Oct; 42(10):815. PubMed ID: 7876052
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary experience using short-term intravenous infusion of streptokinase in the first few hours of acute myocardial infarction].
    Wiernikowski A
    Kardiol Pol; 1986; 29(10):660-6. PubMed ID: 3586467
    [No Abstract]   [Full Text] [Related]  

  • 13. [Practical experiences with routine streptokinase treatment in acute myocardial infarction].
    Jensen G; Nielsen JD; Hildebrandt P; Christiansen I
    Ugeskr Laeger; 1988 Jul; 150(30):1839-41. PubMed ID: 3413854
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary dysfunction associated with streptokinase therapy.
    Kerstein MD; Adinolfi MF
    Arch Surg; 1986 Jul; 121(7):852-3. PubMed ID: 3718220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
    Rothbard RL; Anderson JL; Fitzpatrick PG; Hakworthy RA; Sorensen SG; Marder VJ
    Clin Cardiol; 1990 Mar; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and efficacy of streptokinase in coronary reperfusion in patients with acute myocardial infarction.
    Hu D
    Chin Med J (Engl); 1995 Apr; 108(4):291-4. PubMed ID: 7789218
    [No Abstract]   [Full Text] [Related]  

  • 17. Streptokinase morbidity--more common than previously recognised.
    Siebert WJ; Ayres RW; Bulling MT; Thomas CM; Minson RB; Aylward PE
    Aust N Z J Med; 1992 Apr; 22(2):129-33. PubMed ID: 1388352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity vasculitis associated with streptokinase.
    Manoharan A; Ramsay D; Davis S; Lvoff R
    Aust N Z J Med; 1986 Dec; 16(6):815-6. PubMed ID: 3471202
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasmacytosis and renal failure after readministration of streptokinase for threatened myocardial reinfarction.
    Chan NS; White H; Maslowski A; Cleland J
    BMJ; 1988 Sep; 297(6650):717-8. PubMed ID: 3147737
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous streptokinase in acute myocardial infarction at the community hospital: a six-year experience.
    Vogel JH; Setty RK; Coughlin BJ; Avolio RM; McFadden RB
    Am J Cardiol; 1988 Dec; 62(18):25K-27K. PubMed ID: 3195495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.